LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 26

Search options

  1. Article: Bacterial Biofilm in Chronic Wounds and Possible Therapeutic Approaches.

    Cavallo, Ilaria / Sivori, Francesca / Mastrofrancesco, Arianna / Abril, Elva / Pontone, Martina / Di Domenico, Enea Gino / Pimpinelli, Fulvia

    Biology

    2024  Volume 13, Issue 2

    Abstract: Wound repair and skin regeneration is a very complex orchestrated process that is generally composed of four phases: hemostasis, inflammation, proliferation, and remodeling. Each phase involves the activation of different cells and the production of ... ...

    Abstract Wound repair and skin regeneration is a very complex orchestrated process that is generally composed of four phases: hemostasis, inflammation, proliferation, and remodeling. Each phase involves the activation of different cells and the production of various cytokines, chemokines, and other inflammatory mediators affecting the immune response. The microbial skin composition plays an important role in wound healing. Indeed, skin commensals are essential in the maintenance of the epidermal barrier function, regulation of the host immune response, and protection from invading pathogenic microorganisms. Chronic wounds are common and are considered a major public health problem due to their difficult-to-treat features and their frequent association with challenging chronic infections. These infections can be very tough to manage due to the ability of some bacteria to produce multicellular structures encapsulated into a matrix called biofilms. The bacterial species contained in the biofilm are often different, as is their capability to influence the healing of chronic wounds. Biofilms are, in fact, often tolerant and resistant to antibiotics and antiseptics, leading to the failure of treatment. For these reasons, biofilms impede appropriate treatment and, consequently, prolong the wound healing period. Hence, there is an urgent necessity to deepen the knowledge of the pathophysiology of delayed wound healing and to develop more effective therapeutic approaches able to restore tissue damage. This work covers the wound-healing process and the pathogenesis of chronic wounds infected by biofilm-forming pathogens. An overview of the strategies to counteract biofilm formation or to destroy existing biofilms is also provided.
    Language English
    Publishing date 2024-02-09
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2661517-4
    ISSN 2079-7737
    ISSN 2079-7737
    DOI 10.3390/biology13020109
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Short Communication: HIV Viral Load Trends During the Coronavirus Disease 2019 Pandemic in a Reference Center for HIV in Rome, Italy.

    Latini, Alessandra / Donà, Maria Gabriella / Giuliani, Massimo / Pontone, Martina / Ancona, Carola / Foracappa, Silvia / Morrone, Aldo / Zaccarelli, Mauro

    AIDS research and human retroviruses

    2021  Volume 37, Issue 8, Page(s) 624–626

    Abstract: Coronavirus disease 2019 (COVID-19) pandemic has reduced the access of HIV patients to reference centers. However, retention-in-care is critical to maintain adherence to therapy and viral suppression. During lockdown in Italy, our center implemented ... ...

    Abstract Coronavirus disease 2019 (COVID-19) pandemic has reduced the access of HIV patients to reference centers. However, retention-in-care is critical to maintain adherence to therapy and viral suppression. During lockdown in Italy, our center implemented several measures to ensure HIV-care continuum. To assess whether these efforts were successful, we investigated HIV viral load trend for a 1-year period (September 2019-August 2020), which included lockdown and partial lockdown months in our country. No significant changes overtime in the proportion of undetectable HIV-RNA were observed. Continuity of service made it possible to maintain viral suppression in our patients.
    MeSH term(s) COVID-19/epidemiology ; COVID-19/prevention & control ; Communicable Disease Control ; Female ; HIV Infections/drug therapy ; HIV Infections/epidemiology ; HIV Infections/virology ; Humans ; Male ; Medication Adherence/statistics & numerical data ; Pandemics ; Rome/epidemiology ; SARS-CoV-2 ; Viral Load
    Language English
    Publishing date 2021-05-10
    Publishing country United States
    Document type Journal Article
    ZDB-ID 639130-8
    ISSN 1931-8405 ; 0889-2229
    ISSN (online) 1931-8405
    ISSN 0889-2229
    DOI 10.1089/AID.2021.0044
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Optimizing the Illumina COVIDSeq laboratorial and bioinformatics pipeline on thousands of samples for SARS-CoV-2 Variants of Concern tracking

    Donzelli, Sara / Ciuffreda, Ludovica / Pontone, Martina / Betti, Martina / Massacci, Alice / Mottini, Carla / De Nicola, Francesca / Orlandi, Giulia / Goeman, Frauke / Giuliani, Eugenia / Sperandio, Eleonora / Piaggio, Giulia / Morrone, Aldo / Ciliberto, Gennaro / Fanciulli, Maurizio / Blandino, Giovanni / Pimpinelli, Fulvia / Pallocca, Matteo

    Computational and Structural Biotechnology Journal. 2022, v. 20

    2022  

    Abstract: The SARS-CoV-2 Variants of Concern tracking via Whole Genome Sequencing represents a pillar of public health measures for the containment of the pandemic. The ability to track down the lineage distribution on a local and global scale leads to a better ... ...

    Institution ISG COVID Team
    Abstract The SARS-CoV-2 Variants of Concern tracking via Whole Genome Sequencing represents a pillar of public health measures for the containment of the pandemic. The ability to track down the lineage distribution on a local and global scale leads to a better understanding of immune escape and to adopting interventions to contain novel outbreaks. This scenario poses a challenge for NGS laboratories worldwide that are pressed to have both a faster turnaround time and a high-throughput processing of swabs for sequencing and analysis. In this study, we present an optimization of the Illumina COVID-seq protocol carried out on thousands of SARS-CoV-2 samples at the wet and dry level. We discuss the unique challenges related to processing hundreds of swabs per week such as the tradeoff between ultra-high sensitivity and negative contamination levels, cost efficiency and bioinformatics quality metrics.
    Keywords Severe acute respiratory syndrome coronavirus 2 ; bioinformatics ; biotechnology ; cost effectiveness ; genome ; pandemic ; public health
    Language English
    Size p. 2558-2563.
    Publishing place Elsevier B.V.
    Document type Article
    ZDB-ID 2694435-2
    ISSN 2001-0370
    ISSN 2001-0370
    DOI 10.1016/j.csbj.2022.05.033
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  4. Article: Immunogenicity and Safety of BNT162b2 Homologous Booster Vaccination in People Living with HIV under Effective cART.

    Gianserra, Laura / Donà, Maria Gabriella / Giuliani, Eugenia / Stingone, Christof / Pontone, Martina / Buonomini, Anna Rita / Giuliani, Massimo / Pimpinelli, Fulvia / Morrone, Aldo / Latini, Alessandra

    Vaccines

    2022  Volume 10, Issue 8

    Abstract: Data on COVID-19 boosting vaccination in people living with HIV (PLWH) are scant. We investigated the immunogenicity and safety of the BNT162b2 homologous boosting vaccination. Anti-SARS-CoV-2 spike antibodies (LIAISON® SARS-CoV-2 S1/S2 IgG test, ... ...

    Abstract Data on COVID-19 boosting vaccination in people living with HIV (PLWH) are scant. We investigated the immunogenicity and safety of the BNT162b2 homologous boosting vaccination. Anti-SARS-CoV-2 spike antibodies (LIAISON® SARS-CoV-2 S1/S2 IgG test, DiaSorin®), CD4+, CD8+ and viraemia were monitored at T0 (pre-vaccination), T1 (4 weeks after the second dose), T2 (pre-booster) and T3 (4 weeks after the booster dose). Humoral responses were evaluated according to sex, age, BMI, nadir and baseline CD4+ counts, as well as type of cART regimen. Forty-two subjects were included: the median age was 53 years (IQR: 48−61); the median time since HIV was 12.4 years (IQR: 6.5−18.3); the median nadir and baseline CD4+ counts were 165 (IQR: 104−291) and 687 cells/mm3 (IQR: 488−929), respectively. The booster dose was administered at a median of 5.5 months after the second dose. Median anti-SARS-CoV-2 IgG concentration had significantly decreased at T2 compared to T1 (107 vs. 377, p < 0.0001). Antibody levels elicited by the booster dose (median: 1580 AU/mL) were significantly higher compared with those of all the other time points (p < 0.0001). None of the investigated variables significantly affected antibody response induced by the booster dose. Local and systemic side-effects were referred by 23.8% and 14.3% of the subjects, respectively. One patient developed sensorineural hearing loss (SNHL) 24 h after boosting. He recovered auditory function upon endothympanic administration of corticosteroids. The BNT162b2 boosting vaccination in PLWH is safe and greatly increased the immune response with respect to the primary vaccination.
    Language English
    Publishing date 2022-08-03
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2703319-3
    ISSN 2076-393X
    ISSN 2076-393X
    DOI 10.3390/vaccines10081243
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV - but HIV viremia matters?

    Gianserra, Laura / Donà, Maria Gabriella / Giuliani, Eugenia / Stingone, Christof / Pontone, Martina / Buonomini, Anna Rita / Giuliani, Massimo / Pimpinelli, Fulvia / Morrone, Aldo / Latini, Alessandra

    AIDS (London, England)

    2022  Volume 36, Issue 9, Page(s) 1319–1320

    MeSH term(s) Antibodies, Viral ; BNT162 Vaccine ; COVID-19/prevention & control ; COVID-19 Vaccines ; HIV Infections ; Humans ; RNA, Messenger ; SARS-CoV-2 ; Seroconversion ; Vaccination ; Viremia
    Chemical Substances Antibodies, Viral ; COVID-19 Vaccines ; RNA, Messenger ; BNT162 Vaccine (N38TVC63NU)
    Language English
    Publishing date 2022-06-21
    Publishing country England
    Document type Journal Article ; Comment
    ZDB-ID 639076-6
    ISSN 1473-5571 ; 0269-9370 ; 1350-2840
    ISSN (online) 1473-5571
    ISSN 0269-9370 ; 1350-2840
    DOI 10.1097/QAD.0000000000003239
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Immunogenicity of three doses of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologics.

    Graceffa, Dario / Sperati, Francesca / Bonifati, Claudio / Spoletini, Gabriele / Lora, Viviana / Pimpinelli, Fulvia / Pontone, Martina / Pellini, Raul / Di Bella, Ornella / Morrone, Aldo / Cristaudo, Antonio

    Frontiers in medicine

    2022  Volume 9, Page(s) 961904

    Abstract: Introduction: Psoriasis has not been directly linked to a poor prognosis for COVID-19, yet immunomodulatory agents used for its management may lead to increased vulnerability to the dangerous complications of SARS-CoV-2 infection, as well as impair the ... ...

    Abstract Introduction: Psoriasis has not been directly linked to a poor prognosis for COVID-19, yet immunomodulatory agents used for its management may lead to increased vulnerability to the dangerous complications of SARS-CoV-2 infection, as well as impair the effectiveness of the recently introduced vaccines. The three-dose antibody response trend and the safety of BNT162b2 mRNA vaccine in psoriasis patients treated with biologic drugs have remained under-researched.
    Materials and methods: Forty-five psoriatic patients on biologic treatment were enrolled to evaluate their humoral response to three doses of BNT162b2. IgG titers anti-SARS-CoV-2 spike protein were evaluated at baseline (day 0, first dose), after 3 weeks (second dose), four weeks post-second dose, at the time of the third dose administration and 4 weeks post-third dose. Seropositivity was defined as IgG ≥15 antibody-binding units (BAU)/mL. Data on vaccine safety were also collected by interview at each visit.
    Results: A statistically significant increase in antibody titers was observed after each dose of vaccine compared with baseline, with no significant differences between patients and controls. Methotrexate used in combination with biologics has been shown to negatively influence the antibody response to the vaccine. On the contrary, increasing body mass index (BMI) positively influenced the antibody response. No adverse effects were reported, and no relapses of psoriasis were observed in the weeks following vaccine administration in our study population.
    Conclusions: Our data are largely consistent with the recent literature on this topic confirming the substantial efficacy and safety of BNT162b2 mRNA vaccine on psoriatic patients treated with biologics of different types and support the recommendation to perform additional doses in this specific subgroup of patients.
    Language English
    Publishing date 2022-09-06
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2775999-4
    ISSN 2296-858X
    ISSN 2296-858X
    DOI 10.3389/fmed.2022.961904
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Biofilm Producing Salmonella Typhi: Chronic Colonization and Development of Gallbladder Cancer.

    Di Domenico, Enea Gino / Cavallo, Ilaria / Pontone, Martina / Toma, Luigi / Ensoli, Fabrizio

    International journal of molecular sciences

    2017  Volume 18, Issue 9

    Abstract: Salmonella ... ...

    Abstract Salmonella enterica
    Language English
    Publishing date 2017-08-31
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms18091887
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects.

    Laquintana, Valentina / Mottini, Carla / Marchesi, Francesco / Marcozzi, Benedetta / Terrenato, Irene / Sperandio, Eleonora / de Latouliere, Luisa / Carrieri, Francesca / Pimpinelli, Fulvia / Pontone, Martina / Pellini, Raul / Campo, Flaminia / Conti, Laura / Accetta, Celeste / Mandoj, Chiara / Petrone, Fabrizio / Di Bella, Ornella / Vujovic, Branka / Morrone, Aldo /
    Compagnone, Mirco / Principato, Eugenia / Pinto, Eleonora / Papa, Elena / Falcucci, Paolo / La Malfa, Antonia / Pallocca, Matteo / De Marco, Federico / Piaggio, Giulia / Ciliberto, Gennaro / Mengarelli, Andrea / di Martino, Simona

    Frontiers in immunology

    2024  Volume 14, Page(s) 1221587

    Abstract: Background: Few data are available about the durability of the response, the induction of neutralizing antibodies, and the cellular response upon the third dose of the anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in hemato- ... ...

    Abstract Background: Few data are available about the durability of the response, the induction of neutralizing antibodies, and the cellular response upon the third dose of the anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in hemato-oncological patients.
    Objective: To investigate the antibody and cellular response to the BNT162b2 vaccine in patients with hematological malignancy.
    Methods: We measured SARS-CoV-2 anti-spike antibodies, anti-
    Results: An increase in anti-S1/S2 antigen antibodies compared to T0 was observed in the three groups at T post-3D. After the third vaccine dose, the median antibody level of FHM subjects was higher than after the second dose and above the putative protection threshold, although lower than in the other groups. The neutralizing activity of antibodies against the
    Conclusion: FHM have a relevant response to the BNT162b2 vaccine, with increasing antibody levels after the third dose coupled with, although low, a T-cell response. FHM need repeated vaccine doses to attain a protective immunological response.
    MeSH term(s) Humans ; COVID-19 Vaccines ; BNT162 Vaccine ; COVID-19/prevention & control ; SARS-CoV-2 ; Antibodies, Neutralizing ; Antibodies, Viral ; Hematologic Neoplasms ; Spike Glycoprotein, Coronavirus
    Chemical Substances COVID-19 Vaccines ; BNT162 Vaccine ; spike protein, SARS-CoV-2 ; Antibodies, Neutralizing ; Antibodies, Viral ; Spike Glycoprotein, Coronavirus
    Language English
    Publishing date 2024-01-26
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2023.1221587
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Skin dysbiosis and Cutibacterium acnes biofilm in inflammatory acne lesions of adolescents.

    Cavallo, Ilaria / Sivori, Francesca / Truglio, Mauro / De Maio, Flavio / Lucantoni, Federica / Cardinali, Giorgia / Pontone, Martina / Bernardi, Thierry / Sanguinetti, Maurizio / Capitanio, Bruno / Cristaudo, Antonio / Ascenzioni, Fiorentina / Morrone, Aldo / Pimpinelli, Fulvia / Di Domenico, Enea Gino

    Scientific reports

    2022  Volume 12, Issue 1, Page(s) 21104

    Abstract: Acne vulgaris is a common inflammatory disorder affecting more than 80% of young adolescents. Cutibacterium acnes plays a role in the pathogenesis of acne lesions, although the mechanisms are poorly understood. The study aimed to explore the microbiome ... ...

    Abstract Acne vulgaris is a common inflammatory disorder affecting more than 80% of young adolescents. Cutibacterium acnes plays a role in the pathogenesis of acne lesions, although the mechanisms are poorly understood. The study aimed to explore the microbiome at different skin sites in adolescent acne and the role of biofilm production in promoting the growth and persistence of C. acnes isolates. Microbiota analysis showed a significantly lower alpha diversity in inflammatory lesions (LA) than in non-inflammatory (NI) lesions of acne patients and healthy subjects (HS). Differences at the species level were driven by the overabundance of C. acnes on LA than NI and HS. The phylotype IA1 was more represented in the skin of acne patients than in HS. Genes involved in lipids transport and metabolism, as well as potential virulence factors associated with host-tissue colonization, were detected in all IA1 strains independently from the site of isolation. Additionally, the IA1 isolates were more efficient in early adhesion and biomass production than other phylotypes showing a significant increase in antibiotic tolerance. Overall, our data indicate that the site-specific dysbiosis in LA and colonization by virulent and highly tolerant C. acnes phylotypes may contribute to acne development in a part of the population, despite the universal carriage of the microorganism. Moreover, new antimicrobial agents, specifically targeting biofilm-forming C. acnes, may represent potential treatments to modulate the skin microbiota in acne.
    MeSH term(s) Humans ; Adolescent ; Acne Vulgaris
    Language English
    Publishing date 2022-12-06
    Publishing country England
    Document type Journal Article
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-022-25436-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Continuing evidence that COVID-19 has influenced syphilis epidemiology in Rome.

    Latini, Alessandra / Magri, Francesca / Giuliani, Eugenia / Giuliani, Massimo / Garelli, Valentina / Pontone, Martina / Salvi, Monica / Stingone, Christof / Gianserra, Laura / Pimpinelli, Fulvia / Buonomini, Anna Rita / Morrone, Aldo / Donà, Maria Gabriella / Zaccarelli, Mauro

    Sexually transmitted infections

    2021  Volume 98, Issue 1, Page(s) 72

    MeSH term(s) COVID-19 ; Humans ; Quarantine ; Rome/epidemiology ; SARS-CoV-2 ; Syphilis/epidemiology
    Language English
    Publishing date 2021-09-20
    Publishing country England
    Document type Letter
    ZDB-ID 1420303-0
    ISSN 1472-3263 ; 1368-4973
    ISSN (online) 1472-3263
    ISSN 1368-4973
    DOI 10.1136/sextrans-2021-055250
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top